State of Medical Device Security, Part 2: The Regulator's ViewSuzanne Schwartz of the FDA on the Government's Role in Mitigating Risks
The U.S. Food and Drug Administration lssued cybersecurity expectations for manufacturers of medical devices. But how are those expectations being met, and what is the FDA's ongoing role in improving device security? The FDA's Suzanne Schwartz offers an update.
See Also: HIPAA Audits: A Revised Game Plan
In an interview at Information Security Media Group's recent Healthcare Security Summit in New York, Schwartz discusses:
- How the device security debate has evolved;
- The FDA's role in improving and ensuring device security;
- Milestones that must be met in 2018 to make further progress.
This is part 2 of a three-part video interview series on medical device security. Look for the other two interviews, which feature Dale Nordenberg of the Medical Device Innovation, Safety and Security Consortium and Jennings Aske of New York-Presbyterian.
Having served many roles within the FDA, Dr. Schwartz currently serves as the associate director for science and strategic partnerships at the FDA's Center for Devices and Radiological Health. In this capacity, she assists in the development, execution and evaluation of the center's biomedical science and engineering programs and oversees CDRH's activities related to the Medical Device Innovation Consortium.